DIM
ABBV icon

DC Investments Management’s AbbVie ABBV Stock Holding History

DC Investments Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,836
Closed -$1.48M – 54
2020
Q3 		$1.48M Buy
16,836
+5,718
+51% +$538K 1.61% 16
2020
Q2 		$1.09M Buy
11,118
+4,695
+73% +$413K 0.4% 24
2020
Q1 		$489K Buy
+6,423
New +$547K 0.4% 72
2019
Q4 		– Sell
-2,651
Closed -$201K – 233
2019
Q3 		$201K Sell
2,651
-2,685
-50% -$184K 0.12% 298
2019
Q2 		$388K Buy
+5,336
New +$419K 0.22% 196

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DC Investments Management's ABBV Position: Q4 2020 in Review

DC Investments Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 16,836 shares — an estimated $1.48M sold.

DC Investments Management first reported a position in ABBV in Q2 2019 and held it in 5 quarters. The position peaked at $1.48M in Q3 2020. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • DC Investments Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • DC Investments Management sold 16,836 AbbVie shares in Q4 2020, an estimated $1.48M.
  • DC Investments Management first reported a position in AbbVie in Q2 2019 and held it in 5 quarters.
  • DC Investments Management's AbbVie position peaked at $1.48M in Q3 2020.
  • 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on DC Investments Management's 13F filing for Q4 2020, filed 12 Feb 2021.